Parnian Zia-Amirhosseini, Ph.D.

Parnian Zia-Amirhosseini, Ph.D.

Dr. Parnian Zia-Amirhosseini is Obsidian's Vice President and Head of Regulatory Affairs and Quality Assurance, where she leads Obsidian’s regulatory efforts and will oversee all product quality initiatives. Dr. Zia-Amirhosseini brings to Obsidian 25 years of experience in drug development. She has led regulatory activities for both early and late-stage development programs in multiple therapeutic areas including oncology. Prior to joining Obsidian, Dr. Zia-Amirhosseini was the Executive Director of Regulatory Affairs at Sarepta Therapeutics and the Executive Director of Regulatory Affairs and Quality Assurance at Ambrx. Prior to Ambrx, she worked at Amgen for 14 years, in roles of increasing responsibility, concluding her time as the Global Regulatory Leader for oncology, bone and inflammation projects. She started her career as a reviewer at the Office of Clinical Pharmacology and Biopharmaceutics at FDA. Dr. Zia-Amirhosseini holds a Ph.D. from the University of California, San Francisco, in Pharmaceutical Chemistry.



< Back to Management